Federal Data Hub › HRSA 340B · JSON

UNIVERSITY OF TEXAS

SOUTHWESTERN MEDICAL CENTER · 340B ID HM12019

ParticipatingHemophilia Treatment Center

UNIVERSITY OF TEXAS is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in DALLAS, TX. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 10 contract-pharmacy arrangement(s) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (10)

PharmacyLocationBeginTerminatedPharmacy ID
ACCREDO HEALTH GROUP INCTEMPE, AZ2026-04-01—75292
ACCREDO HEALTH GROUP INCNEW ORLEANS, LA2026-04-01—64235
ACCREDO HEALTH GROUP INCWARRENDALE, PA2026-04-01—23041
ACCREDO HEALTH GROUP INCMEMPHIS, TN2026-04-01—45979
ACCREDO HEALTH GROUP INCHOUSTON, TX2026-04-01—69920
ACCREDO HEALTH GROUP INCIRVING, TX2026-04-01—67543
ACCREDO HEALTH GROUP, INC.ORLANDO, FL2026-04-01—39194
ACCREDO HEALTH GROUP, INC.LENEXA, KS2026-04-01—62883
POSITUDES INCWESTBURY, NY2021-01-01—8621
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CHOUSTON, TX2003-07-01—1083

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.